Prognostic role of TAPSE to PASP ratio in outpatients with left ventricular systolic dysfunction

Abstract Aims Few data are available regarding the role of tricuspid annulus plane systolic excursion to pulmonary artery systolic pressure (TAPSE/PASP), a measurement of right ventricular to pulmonary artery coupling, in patients with chronic heart failure and left ventricular systolic dysfunction. Methods and results This retrospective single‐centre study included outpatients with left ventricular systolic dysfunction (ejection fraction ≤ 50%) evaluated between January 2022 and December 2022. TAPSE/PASP was evaluated as a continuous variable and as tertiles according to its value on the first visit. The primary outcome of the study was a composite of all‐cause mortality or heart failure (HF) events at the last available follow‐up. Results A total of 642 patients were included (mean age 71 ± 13 years, 78% male, mean left ventricular ejection fraction 40% [interquatile range 35–46]). Patients with lower TAPSE/PASP had more co‐morbidities (i.e., atrial fibrillation, chronic kidney disease or previous cardiovascular implantable electronic device), an higher New York Heart Association class ( P < 0.001), more signs of congestion ( P = 0.007), and had more probability to receive intravenous furosemide during the visit ( P < 0.001). After a median follow‐up of 474 days [interquartile range 392–507 days], a total of 51 patients (8.0%) died (with 24 patients [3.8%] experiencing cardiovascular‐related deaths), a total of 179 patients (28.1%) experienced a composite outcome, and 158 patients (24.8%) had HF events. Kaplan–Meier analysis showed that the estimated 1‐year rate of the primary outcome was higher in the lowest tertile (38.0%), as compared with the intermediate (19.6%) and highest tertiles (14.9%; P ‐value log‐rank <0.001). TAPSE/PASP ratio as a continuous variable was independently associated with the primary outcome (adjusted hazard ratio for 0.1 mm/mmHg increase 0.91, 95% CI 0.84–0.98, P = 0.009), predominantly driven by a higher risk of HF events during follow‐up. Analysing the impact of TAPSE/PASP tertiles on the primary outcome, an independent associated was confirmed at multivariate analisys for the highest versus lowest tertile (adjusted hazard ratio 0.61, 95% CI 0.38–0.99, P = 0.044). Conclusions TAPSE/PASP was independently associated with mortality or HF events among ambulatory patients with left ventricular systolic dysfunction.